文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

宿主对重症甲型流感病毒感染的易感性

Host susceptibility to severe influenza A virus infection.
PubMed 文献 · Crit Care · 2019-09-05
一句话结论重症流感患者按定义即为异常宿主,其易感性涉及遗传变异、干扰素反应缺陷及细胞免疫异常等机制。

大多数暴露于新型流感病毒的人无症状,仅少数发展为危重症。易感性差异部分由初始接种量、流感暴露史或虚弱等一般宿主因素解释,部分人口学因素(妊娠、肥胖、高龄)似乎 confer 更特异的易感性。宿主遗传学是易感性的重要组成部分,已报道多种遗传易感变异,包括 IFITM3、TMPRS22 变异(细胞内病毒复制控制受损)、GLDC、IRF7/9 变异(干扰素反应缺陷)以及细胞免疫缺陷伴基线全身炎症升高(肥胖、妊娠、高龄)。这些机制可能解释危重症患者中报告的病毒复制延长。

要点

  • 重症流感患者按定义即为异常宿主,其病毒复制延长可能与宿主遗传或免疫缺陷相关。
  • 已报道的遗传易感变异涉及细胞内病毒复制控制受损(如 IFITM3、TMPRS22 变异)和干扰素反应缺陷(如 GLDC、IRF7/9 变异)。
  • 肥胖、妊娠和高龄与细胞免疫缺陷及基线全身炎症升高相关,可能 confer 对重症流感的更特异易感性。
  • 初始接种量大小和个体流感暴露史可部分解释易感性差异。
  • 理解易感性的分子机制可能在未来 enable 设计宿主导向治疗以促进 resilience。

适用人群与场景

  • 暴露于新型流感病毒的人群,大多数无症状,仅少数发展为危重症。

研究设计与关键结果

  • 综述指出大多数暴露者无症状,小部分发展为危重症;易感性差异部分由初始接种量、流感暴露史、虚弱等一般宿主因素解释,部分由妊娠、肥胖、高龄等人口学因素 confer 更特异易感性;宿主遗传学是重要组成部分,已报道多种遗传易感变异(如 IFITM3、TMPRS22、GLDC、IRF7/9 变异),涉及细胞内病毒复制控制受损、干扰素反应缺陷或细胞免疫缺陷伴基线全身炎症升高;这些机制可能解释危重症患者中报告的病毒复制延长。

对床旁实践的改变

  • 作者认为,理解这些易感性分子机制可能在未来 enable 设计宿主导向治疗以促进 resilience。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「证据类型、等级与局限」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Most people exposed to a new flu virus do not notice any symptoms. A small minority develops critical illness. Some of this extremely broad variation in susceptibility is explained by the size of the initial inoculum or the influenza exposure history of the individual; some is explained by generic host factors, such as frailty, that decrease resilience following any systemic insult. Some demographic factors (pregnancy, obesity, and advanced age) appear to confer a more specific susceptibility to severe illness following infection with influenza viruses. As with other infectious diseases, a substantial component of susceptibility is determined by host genetics. Several genetic susceptibility variants have now been reported with varying levels of evidence. Susceptible hosts may have impaired intracellular controls of viral replication (e.g. IFITM3, TMPRS22 variants), defective interferon responses (e.g. GLDC, IRF7/9 variants), or defects in cell-mediated immunity with increased baseline levels of systemic inflammation (obesity, pregnancy, advanced age). These mechanisms may explain the prolonged viral replication reported in critically ill patients with influenza: patients with life-threatening disease are, by definition, abnormal hosts. Understanding these molecular mechanisms of susceptibility may in the future enable the design of host-directed therapies to promote resilience.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Clohisey S, Baillie JK. Host susceptibility to severe influenza A virus infection. Crit Care. 2019. PMID: 31488196. doi:10.1186/s13054-019-2566-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。